JP 1302
Alternative Names: JP-1302Latest Information Update: 16 Feb 2009
At a glance
- Originator Juvantia Pharma
- Class Antiparkinsonians; Imidazoles; Indans; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 01 Feb 2001 Preclinical development for Depression in United Kingdom (Unknown route)